CIK 0001048477 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2022 | FY2021 | |
|---|---|---|---|---|
| Revenue (USD) | 3.2 B | 2.1 B | ||
| Net income (USD) | 854.0 M | -23.8 M | ||
| Diluted EPS (USD/shares) | 1.8 | 0.75 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-06 | 8-K | 8-K items 2.02 | 2026-10-06 |
| 2026-10-01 | 4 | FORM 4 | 2026-09-30 |
| 2026-09-30 | 8-K | 8-K items 1.01 | 2026-09-24 |
| 2026-09-15 | 8-K | 8-K items 8.01 | 2026-09-15 |
| 2026-09-14 | 4 | FORM 4 | 2026-09-10 |
| 2026-09-14 | 3 | FORM 3 | 2026-09-10 |
| 2026-09-14 | 8-K | 8-K items 5.02 | 2026-09-10 |
| 2026-09-03 | 4 | FORM 4 | 2026-09-02 |
| 2026-09-02 | 144 | 144 | |
| 2026-09-01 | 8-K | 8-K items 8.01 | 2026-08-31 |
| 2026-08-31 | 8-K | 8-K items 1.01,7.01,9.01 | 2026-08-30 |
| 2026-08-18 | 8-K | 8-K items 1.01,7.01,9.01 | 2026-08-17 |
| 2026-08-06 | S-8 | S-8 | |
| 2026-08-06 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-06 | 8-K | 8-K items 2.02,9.01 | 2026-08-06 |
| 2026-07-13 | 8-K/A | 8-K/A items 8.01,9.01 | 2026-04-27 |
| 2026-06-04 | 4 | FORM 4 | 2026-06-02 |
| 2026-06-04 | 4 | FORM 4 | 2026-06-02 |
| 2026-06-04 | 4 | FORM 4 | 2026-06-02 |
| 2026-06-04 | 4 | FORM 4 | 2026-06-02 |
| 2026-06-04 | 4 | FORM 4 | 2026-06-02 |
| 2026-06-04 | 4 | FORM 4 | 2026-06-02 |
| 2026-06-04 | 4 | FORM 4 | 2026-06-02 |
| 2026-06-04 | 4 | FORM 4 | 2026-06-02 |
| 2026-06-04 | 4 | FORM 4 | 2026-06-02 |
Forms on file (last 1,000): 4 609, 8-K 106, 144 52, SC 13G/A 47, 10-Q 29, 5 22, 4/A 18, 3 17. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=BMRN (0.002 USD), /gw/filings/filings?ticker=BMRN&form=8-K, /gw/filings/facts?ticker=BMRN&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange